Kyowa Kirin Holdings B.V.
SpainAll drugs from this manufacturer
-
It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) in patients who cannot undergo tumor removal.
Dosage form: solution for injection
Active substance Dosage burosumab 10 mg -
It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) when the tumor cannot be removed or located, also in children, adolescents, and adults.
Dosage form: solution for injection
Active substance Dosage burosumab 20 mg -
It is used to treat X-linked hypophosphatemia (XLH) in children, adolescents, and adults, as well as tumor-induced osteomalacia (TIO) when the tumor cannot be surgically removed or located, also in children, adolescents, and adults.
Dosage form: solution for injection
Active substance Dosage burosumab 30 mg -
It is used to treat adults with cutaneous T-cell lymphoma types called mycosis fungoides and Sézary syndrome, in patients who have already received at least one prior systemic therapy (oral or injectable).
Dosage form: solution for infusion, concentrate
Active substance Dosage mogamulizumab 20 mg